Related Experiment Video
Updated: Apr 26, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Understanding high-density lipoprotein function in disease: recent advances in proteomics unravel the complexity of
Ruth Birner-Gruenberger1, Matthias Schittmayer1, Michael Holzer2
1Institute of Pathology, Medical University of Graz, Graz, Austria; Omics Center Graz, BioTechMed, Graz, Austria.
Insights
High-density lipoprotein (HDL) cholesterol interventions haven't reduced cardiovascular risk. HDL proteomics reveals diverse proteins, offering potential new biomarkers for disease diagnosis and treatment effectiveness.
Area of Science:
- Biochemistry
- Cardiovascular Research
- Proteomics
Background:
- Epidemiology links HDL cholesterol and cardiovascular risk, but drug interventions targeting HDL-cholesterol haven't improved outcomes.
- HDL particles are protein-rich, with recent advances revealing a complex proteome beyond lipid transport.
- The proteomic complexity of HDL is increasingly recognized, with proteins involved in iron transport, immunity, and acute phase response identified.
Purpose of the Study:
- To review recent advances in HDL proteomics and lipidomics.
- To explore the potential of HDL proteomics for biomarker discovery.
- To understand HDL function in health and disease through proteomic and lipidomic insights.
Main Methods:
- Review of recent scientific literature on HDL proteomics and lipidomics.
- Analysis of proteomic data identifying proteins associated with HDL particles.
- Monitoring of HDL proteome changes in various disease states.
Main Results:
- Proteomics has significantly expanded the understanding of proteins carried by HDL particles.
- HDL particles contain proteins involved in lipid transport, iron transport, complement pathways, immune function, and acute phase response.
- Dynamic changes in HDL subgroups are being discovered, highlighting their complexity.
Conclusions:
- HDL proteomics offers a promising avenue for discovering novel biomarkers for disease diagnosis.
- HDL proteomic analysis can help measure the effectiveness of current and future therapeutic strategies.
- Understanding HDL's complex proteome is crucial for deciphering its role in health and disease.
Abstract:
Although the epidemiology of high-density lipoprotein (HDL) cholesterol and cardiovascular risk has been consistent, pharmacologic interventions to increase HDL-cholesterol by delaying HDL catabolism did not translate into reduction in cardiovascular risk. HDL particles are small, protein-rich when compared to other plasma lipoprotein classes. Latest progresses in proteomics technology have dramatically increased our understanding of proteins carried by HDL. In addition to proteins with well-established functions in lipid transport, iron transport proteins, members of the complement pathway, and proteins involved in immune function and acute phase response were repeatedly identified on HDL particles. With the unraveling of the complexity of the HDL proteome, different laboratories have started to monitor its changes in various disease states. In addition, dynamic aspects of HDL subgroups are being discovered. These recent studies clearly illustrate the promise of HDL proteomics for deriving new biomarkers for disease diagnosis and to measure the effectiveness of current and future treatment regimens. This review summarizes recent advances in proteomics and lipidomics helping to understand HDL function in health and disease.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

